Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
1,565.53
1,541.39
1,715.32
2,124.05
1,324.82
1,013.54
1,310.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,565.53
1,541.39
1,715.32
2,124.05
1,324.82
1,013.54
1,310.86
Raw Material Cost
376.45
433.28
528.62
575.54
608.95
434.02
454.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.80
5.25
2.93
3.07
0.95
1.17
1.54
Selling and Distribution Expenses
914.93
969.54
975.31
834.59
663.72
635.29
764.37
Other Expenses
18.66
26.85
20.39
20.24
21.88
21.99
23.68
Total Expenditure (Excl Depreciation)
1,482.76
1,676.57
1,710.79
1,615.60
1,492.44
1,290.43
1,457.50
Operating Profit (PBDIT) excl Other Income
82.8
-135.2
4.5
508.40000000000003
-167.60000000000002
-276.90000000000003
-146.6
Other Income
53.21
-16.93
59.06
5.27
38.60
39.80
22.73
Operating Profit (PBDIT)
169.73
-123.92
88.81
537.42
-42.78
-181.64
-38.85
Interest
4.80
5.25
2.93
3.07
0.95
1.17
1.54
Exceptional Items
0.26
-275.48
-0.88
0.00
-263.04
14.37
-292.12
Gross Profit (PBDT)
1,189.08
1,108.11
1,186.70
1,548.51
715.87
579.52
856.11
Depreciation
33.75
28.20
25.23
23.70
86.24
55.44
85.06
Profit Before Tax
131.44
-432.84
59.78
510.64
-393.00
-223.88
-417.58
Tax
6.21
16.09
33.41
17.31
-5.03
14.13
-1.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
125.23
-448.93
26.38
493.33
-387.97
-238.00
-415.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
125.23
-448.93
26.38
493.33
-387.97
-238.00
-415.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
125.23
-448.93
26.38
493.33
-387.97
-238.00
-415.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,552.63
1,365.41
1,797.61
1,514.47
828.15
1,093.99
1,161.84
Earnings per share (EPS)
30.81
-110.99
6.98
97.29
-117.5
-73.6
-141.84
Diluted Earnings per share
30.81
-110.99
6.98
97.29
-117.5
-73.6
-141.84
Operating Profit Margin (Excl OI)
5.29%
-8.77%
0.26%
23.94%
-12.65%
-27.32%
-11.19%
Gross Profit Margin
10.55%
-26.25%
4.96%
25.16%
-23.16%
-16.62%
-25.37%
PAT Margin
8.0%
-29.13%
1.54%
23.23%
-29.28%
-23.48%
-31.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 1.56% vs -10.14% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 127.89% vs -1,800.38% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 208.88% vs -459.06% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -7.69% vs 79.31% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of PhoenixBio Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
1,565.53
3,467.59
-1,902.06
-54.85%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,565.53
3,467.59
-1,902.06
-54.85%
Raw Material Cost
376.45
2,475.99
-2,099.54
-84.80%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.80
18.54
-13.74
-74.11%
Selling and Distribution Expenses
914.93
774.60
140.33
18.12%
Other Expenses
18.66
2.05
16.61
810.24%
Total Expenditure (Excl Depreciation)
1,482.76
3,289.67
-1,806.91
-54.93%
Operating Profit (PBDIT) excl Other Income
82.77
177.92
-95.15
-53.48%
Other Income
53.21
26.72
26.49
99.14%
Operating Profit (PBDIT)
169.73
326.58
-156.85
-48.03%
Interest
4.80
18.54
-13.74
-74.11%
Exceptional Items
0.26
139.57
-139.31
-99.81%
Gross Profit (PBDT)
1,189.08
991.60
197.48
19.92%
Depreciation
33.75
153.76
-120.01
-78.05%
Profit Before Tax
131.44
293.85
-162.41
-55.27%
Tax
6.21
85.87
-79.66
-92.77%
Provisions and contingencies
0
0
0.00
Profit After Tax
125.23
207.98
-82.75
-39.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
125.23
207.98
-82.75
-39.79%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
125.23
207.98
-82.75
-39.79%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,552.63
3,532.52
-1,979.89
-56.05%
Earnings per share (EPS)
30.81
37.14
-6.33
-17.04%
Diluted Earnings per share
30.81
37.14
-6.33
-17.04%
Operating Profit Margin (Excl OI)
5.29%
4.21%
0.00
1.08%
Gross Profit Margin
10.55%
12.91%
0.00
-2.36%
PAT Margin
8.00%
6.00%
0.00
2.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 156.55 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 1.56% vs -10.14% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 12.52 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 127.89% vs -1,800.38% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.65 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 208.88% vs -459.06% in Mar 2025
Annual - Interest
Interest 0.48 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -7.69% vs 79.31% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.29%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
